ProCE Banner Activity

Pharmacists’ FAQs on the Novel Approaches in the Management of Acute and Chronic GVHD

Clinical Thought
Read this commentary from Eno-Abasi Inyang, PharmD, BCPS, BCOP, and Marissa Olson, PharmD, BCOP, on frequently asked questions regarding pharmacists’ use of novel approaches in the management of acute and chronic GVHD.

Released: February 01, 2022

Expiration: January 31, 2023

No longer available for credit.

Share

Faculty

Eno-Abasi Inyang

Eno-Abasi Inyang, PharmD, BCOP, BCPS

Stem Cell Transplant Clinical Pharmacy Specialist
Pharmacy Department
Dana Farber Cancer Institute
Boston, Massachusetts

Marissa Olson

Marissa Olson, PharmD, BCOP

Clinical Pharmacy Specialist Hematologic Malignancies/Bone Marrow Transplant
Pharmacy
Barnes-Jewish Hospital
Saint Louis, Missouri

Provided by

Provided by ProCE, LLC
ProCE Banner

Supporters

This activity is supported by an educational grant from

Incyte Corporation

Faculty Disclosure

Primary Author

Eno-Abasi Inyang, PharmD, BCOP, BCPS

Stem Cell Transplant Clinical Pharmacy Specialist
Pharmacy Department
Dana Farber Cancer Institute
Boston, Massachusetts

Eno-Abasi Inyang, PharmD, BCOP, BCPS, has no conflicts of interest to report.

Marissa Olson, PharmD, BCOP

Clinical Pharmacy Specialist Hematologic Malignancies/Bone Marrow Transplant
Pharmacy
Barnes-Jewish Hospital
Saint Louis, Missouri

Marissa Olson, PharmD, BCOP, has no conflicts of interest to report.